RECOMBINANT ADENOVIRAL MEDIATED CD39 GENE TRANSFER PROLONGS CARDIAC XENOGRAFT SURVIVAL1

Abstract

Recombinant adenoviral infection can induce expression of CD39 within cardiac xenografts and provide survival benefits in vivo. Our data show that ex vivo infection by recombinant adenovirus vectors can result in vascular expression of a potential therapeutic agent.